Abstract:
A supramolecular approach has been developed for preparation of size-controllable nanoparticles, from three different molecular building blocks.
Abstract:
Embodiments of the invention include a PET/SPECT reporter gene system that uses enhanced non-immunogenic versions of a human mitochondrial thymidine kinase 2 expressed in cytoplasm to preferentially trap novel PET/SPECT radiolabeled L and D-enantiomer analogs of the natural substrate thymidine. Such highly sensitive, non-immunogenic reporter genes function in combination with a set of novel, radiolabeled probes in whole body molecular imaging applications using positron emission tomography (PET) or single photon emission computed tomography (SPECT).
Abstract:
The invention provides compounds that bind to deoxycytidine kinase (dCK) and compositions including pharmaceutically acceptable compositions containing the compounds. The compounds are useful in treating diseases and disorders where dCK activity is implicated such as cancer and immune disorders. The compounds also find use in clinical methodologies including positron emission tomography (PET) imaging.
Abstract:
Compounds for use as PET probes and methods for synthesizing and using these, comprising [18F]D-FAC and other cytosine and adenosine analogs.
Abstract:
The invention provides compounds that bind to deoxycytidine kinase (dCK) and compositions including pharmaceutically acceptable compositions containing the compounds. The compounds are useful in treating diseases and disorders where dCK activity is implicated such as cancer and immune disorders. The compounds also find use in clinical methodologies including positron emission tomography (PET) imaging.
Abstract:
Compounds for use as PET probes and methods for synthesizing and using these, comprising [18F]D-FAC and other cytosine and adenosine analogs.
Abstract:
A supramolecular approach has been developed for preparation of size-controllable nanoparticles, from three different molecular building blocks.
Abstract:
A detector for use in a dedicated PET scanner for cancer applications, particularly breast cancer applications, using a LSO scintillator, a lightguide coupling arrangement, and an efficient way to construct the scintillator array, which provides a flexible imaging system for breast cancer applications with high sensitivity and high spatial resolution in a compact, cost effective, design.